Tags : Hummingbird Bioscience


Hummingbird Collaborates with Novogene to Expand Precision Therapy Testing for

Shots: The partnership will utilize Novogene’s molecular diagnostics capabilities to expand patient identification by NGS in China for supporting the development of Hummingbird’s HMBD-001 which is expected to enter P-I study in 2021 to treat NRG1-fusion driven cancers The partnership focuses on validation and expansion of clinical-grade testing for NRG1 fusions in patient populations with […]Read More